FDA Approves Dengvaxia (dengue vaccine) for the Prevention of Dengue Disease in Endemic Regions

May 01, 2019 -- The U.S. Food and Drug Administration announced today the approval of Dengvaxia, the first vaccine approved for the prevention of dengue disease caused by all dengue virus serotypes (1, 2, 3 and 4) in people ages 9 through 16 who...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news